CNS Pharmaceuticals, Inc. (CNSP)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.17M |
| Enterprise value | 1.92M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.57 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.09 |
| 52-week change 3 | -86.49% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 2.9800 |
| 52-week low 3 | 0.1900 |
| 50-day moving average 3 | 0.3051 |
| 200-day moving average 3 | 1.2234 |
Share statistics
| Avg vol (3-month) 3 | 412.76k |
| Avg vol (10-day) 3 | 153.4k |
| Shares outstanding 5 | 10.63M |
| Implied shares outstanding 6 | 11.16M |
| Float 8 | 8.95M |
| % held by insiders 1 | 9.53% |
| % held by institutions 1 | 3.53% |
| Shares short (15 Apr 2024) 4 | 23.08k |
| Short ratio (15 Apr 2024) 4 | 0.13 |
| Short % of float (15 Apr 2024) 4 | 0.24% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.22% |
| Shares short (prior month 15 Mar 2024) 4 | 103.79k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 29 Nov 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -159.83% |
| Return on equity (ttm) | -1,018.78% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -18.86M |
| Net income avi to common (ttm) | -18.85M |
| Diluted EPS (ttm) | -10.0000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 548.72k |
| Total cash per share (mrq) | 0.05 |
| Total debt (mrq) | 300.81k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.26 |
| Book value per share (mrq) | -0.71 |
Cash flow statement
| Operating cash flow (ttm) | -14.14M |
| Levered free cash flow (ttm) | -8M |
© 2024 Yahoo. All rights reserved.